Synapse - Works

Results (2146)

Global, phase Ib dose-expansion cohort of E7386 + lenvatinib (LEN) in patients (pts) with advanced (a) endometrial cancer (EC) that progressed on platinum-based chemotherapy (CTx) and an anti-PD-(L)1 immunotherapy (IO)

Meeting Abstract

Lee, J. Y.; Hasegawa, K.; Kim, B. G.; Corr, B. R.; Kondo, S.; Suzuki, S.; Yunokawa, M.; Miller, D. S.; Tamai, T.; Dutta, L.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Characterization of tumor response with lenvatinib plus pembrolizumab (LEN + Pembro) in the ENGOT-en9/LEAP-001 study

Meeting Abstract

Danska-Bidzinska, A.; Makker, V.; Salutari, V.; Ayhan, A.; Romero, I.; Levy, T.; McCormack, M.; Baurain, J. F.; Mach, P.; Cadoo, K. A.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation

Meeting Abstract

Schram, A. M.; Lopes, G.; El-Khoueiry, A. B.; Fontana, E.; Karasic, T. B.; Kummar, S.; Lorusso, P.; Gregorc, V.; Millward, M.; Aix, S. P.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors

Meeting Abstract

Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

First clinical results from a phase I trial of PRT3789: A first-in-class intravenous SMARCA2 degrader, in patients with advanced solid tumors with a SMARCA4 mutation

Meeting Abstract

Guo, R.; Dowlati, A.; Dagogo-Jack, I.; Vibert, J.; Spira, A. I.; Moreno Garcia, V.; Punekar, S.; Calvo, E.; Sonpavde, G. P.; Awad, M.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Final overall survival (OS) in patients (pts) with newly diagnosed advanced ovarian cancer (aOC) treated with niraparib (nir) first-line (1L) maintenance: Results from PRIMA/ENGOT-OV26/GOG-3012

Meeting Abstract

González-Martín, A.; Pothuri, B.; Ginesta, M. P. B.; Graybill, W. S.; Vergote, I. B.; McCormick, C.; Mirza, M. R.; Moore, R. G.; Lorusso, D.; O'Cearbhaill, R. E.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

An open-label, multicenter, phase II study of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) part 2

Meeting Abstract

Lee, J. Y.; Makker, V.; Oaknin, A.; Oh, D. Y.; Anoka, C.; Jung, L.; Simoes, J.; Puvvada, S. D.; Meric-Bernstam, F.
Annals of Oncology (2024)

Fulltext@MSK | Save

Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib

Journal Article

Barnicle, A.; Ray-Coquard, I.; Rouleau, E.; Cadoo, K.; Simpkins, F.; Aghajanian, C.; Leary, A.; Poveda, A.; Lheureux, S.; Pujade-Lauraine, E.; more...
Genome Medicine (2024)

Fulltext@MSK | Save

Comparison of image-guided intensity modulated radiotherapy (IG-IMRT) vs. conventional radiotherapy (4FRT) for locoregionally advanced cervical cancer on the NRG GY006 trial

Meeting Abstract

Mell, L. K.; Deng, W.; Gao, L.; Kunos, C. M.; Chino, J. P.; Quick, A. M.; Feddock, J. M.; Donnelly, E. D.; Albuquerque, K. V.; Leif, J. L.; more...
International Journal of Radiation Oncology, Biology, Physics (2024)

Fulltext@MSK | Save

Image guided brachytherapy quality assurance on NRG GY017, an NRG oncology clinical trial investigating the sequencing of immunotherapy and chemoradiation for locally advanced cervical cancer

Meeting Abstract

Kim, H.; Deng, W.; Nguyen, H.; Leif, J. L.; McNulty, S.; Zamarin, D.; Chino, J. P.; Ghamande, S.; Ferguson, C. L.; Mell, L. K.; more...
International Journal of Radiation Oncology, Biology, Physics (2024)

Fulltext@MSK | Save